Of interest, addition of joint MYC and PTEN status at biopsy to the baseline model that included age, PSA, clinical stage, proportion of positive cores, presence of cribriform or intraductal carcinoma, and percentage of Gleason pattern 4 carcinoma further increased the AUC to 0.75. This evidence concerns the gene MYC and ductal breast carcinoma in situ.